Cargando…

Efficacy of Yishen Huashi Granules Combined with Linagliptin Tablets on Blood Glucose and Renal Function in Patients with Type 2 Diabetic Nephropathy

OBJECTIVE: To probe into the efficacy of Yishen Huashi granules combined with linagliptin tablets in the treatment of type 2 diabetic nephropathy (DN) and its effect on blood glucose and renal function in patients. METHODS: 70 patients with type 2 DN at our hospital between May 2020 and May 2022 wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Panke, Meng, Jingxi, Duan, Mingliang, Li, Dan, Wang, Ruixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514935/ https://www.ncbi.nlm.nih.gov/pubmed/36177313 http://dx.doi.org/10.1155/2022/4272520

Ejemplares similares

Yishen Huashi Granules Ameliorated the Development of Diabetic Nephropathy by Reducing the Damage of Glomerular Filtration Barrier
por: Zhao, Tingting, et al.
Publicado: (2022)

Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways
por: Zhao, Tingting, et al.
Publicado: (2023)

Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy
por: Fang, Jingai, et al.
Publicado: (2022)

Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy
por: Liu, Jie, et al.
Publicado: (2022)

Efficacy and Safety of Huashi Baidu Granules in Treating Patients with SARS-CoV-2 Omicron Variant: A Single-Center Retrospective Cohort Study
por: Chen, Cai-yu, et al.
Publicado: (2023)

Qingchang Huashi granule ameliorates experimental colitis via restoring the dendritic cell-mediated Th17/Treg balance
por: Jia, Jia, et al.
Publicado: (2020)

Yishen Qingli Heluo Granule Ameliorates Renal Dysfunction in 5/6 Nephrectomized Rats by Targeting Gut Microbiota and Intestinal Barrier Integrity
por: Sun, Xian, et al.
Publicado: (2022)

Yishen Qingli Heluo Granule in the Treatment of Chronic Kidney Disease: Network Pharmacology Analysis and Experimental Validation
por: Sun, Xian, et al.
Publicado: (2022)

Empagliflozin/linagliptin single‐tablet combination: first‐in‐class treatment option
por: Woo, V.
Publicado: (2015)

Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway
por: Zhang, Ziyuan, et al.
Publicado: (2022)

Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking
por: Hu, Yaling, et al.
Publicado: (2022)

Inhibitive Effects of Huashi Pill on Formation of Renal Stones by Modulating Urine Biochemical Indexes and Osteopontin in Renal Stone Rat Models
por: Yang, Ailing, et al.
Publicado: (2019)

Chaihuang-Yishen Granule Inhibits Diabetic Kidney Disease in Rats through Blocking TGF-β/Smad3 Signaling
por: Zhao, Ting Ting, et al.
Publicado: (2014)

Bufei Yishen granule combined with acupoint sticking improves pulmonary function and morphormetry in chronic obstructive pulmonary disease rats
por: Tian, Yange, et al.
Publicado: (2015)

Effects of Bufei Yishen Granules Combined with Acupoint Sticking Therapy on Pulmonary Surfactant Proteins in Chronic Obstructive Pulmonary Disease Rats
por: Tian, Yange, et al.
Publicado: (2016)

Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial
por: Chen, Jiande, et al.
Publicado: (2023)

The therapeutic efficacy of Huashi Baidu Formula combined with antiviral drugs in the treatment of COVID-19: A protocol for systematic review and meta-analysis
por: Han, Lizhu, et al.
Publicado: (2020)

Tongluo Yishen Decoction Ameliorates Renal Fibrosis via NLRP3-Mediated Pyroptosis In Vivo and In Vitro
por: Jia, Qi, et al.
Publicado: (2022)

Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy
por: Liu, Yuxiang, et al.
Publicado: (2021)

Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of Bushen Huashi decoction against kidney stones
por: Liu, Haizhao, et al.
Publicado: (2023)

The Efficacy of Hydroxychloroquine Combined with Huangqi Tablets in the Treatment of Diabetic Nephropathy
por: Chen, Xiaorong, et al.
Publicado: (2021)

The effect of linagliptin on microalbuminuria in patients with diabetic nephropathy: a randomized, double blinded clinical trial
por: Karimifar, Mozhgan, et al.
Publicado: (2023)

Effect of Bufei Yishen Granules Combined with Electroacupuncture in Rats with Chronic Obstructive Pulmonary Disease via the Regulation of TLR-4/NF-κB Signaling
por: Ma, Jindi, et al.
Publicado: (2019)

Effects of Yishen Pinggan Recipe on Renal Protection and NF-κB Signaling Pathway in Spontaneously Hypertensive Rats
por: Luo, Guodong, et al.
Publicado: (2016)

Linagliptin: A thorough Characterization beyond Its Clinical Efficacy
por: Sortino, Maria Angela, et al.
Publicado: (2013)

Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment
por: Guedes, Erika Paniago, et al.
Publicado: (2013)

The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast
por: Li, Yangyang, et al.
Publicado: (2020)

Sequential Treatments with Tongsai and Bufei Yishen Granules Reduce Inflammation and Improve Pulmonary Function in Acute Exacerbation-Risk Window of Chronic Obstructive Pulmonary Disease in Rats
por: Lu, Xiaofan, et al.
Publicado: (2016)

Bufei Yishen Granules Combined with Acupoint Sticking Therapy Suppress Inflammation in Chronic Obstructive Pulmonary Disease Rats: Via JNK/p38 Signaling Pathway
por: Tian, Yange, et al.
Publicado: (2017)

Retracted: The Efficacy of Hydroxychloroquine Combined with Huangqi Tablets in the Treatment of Diabetic Nephropathy
por: Engineering, Journal of Healthcare
Publicado: (2023)

The clinical application of linagliptin in Asians
por: Cao, Chu-qing, et al.
Publicado: (2015)

Linagliptin: from bench to bedside
por: Doupis, John
Publicado: (2014)

Corrigendum to “The Antiosteoporosis Effects of Yishen Bugu Ye Based on Its Regulation on the Differentiation of Osteoblast and Osteoclast”
por: Li, Yangyang, et al.
Publicado: (2021)

Mechanism of Jianpi Qingchang Huashi Recipe in treating ulcerative colitis: A study based on network pharmacology and molecular docking
por: Zheng, Lie, et al.
Publicado: (2021)

Analyzing the potential therapeutic mechanism of Huashi Baidu Decoction on severe COVID-19 through integrating network pharmacological methods
por: Zhu, Yi-Wei, et al.
Publicado: (2021)

Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF/MS
por: WEI, Wen-Long, et al.
Publicado: (2021)

Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19
por: Xu, Haiyu, et al.
Publicado: (2023)

Pharmacokinetics of a Fixed-Dose Combination Product of Dapagliflozin and Linagliptin and Its Comparison with Co-Administration of Individual Tablets in Healthy Humans
por: Park, Jin-Woo, et al.
Publicado: (2022)

Formulation design of granules prepared by wet granulation method using a multi-functional single-punch tablet press to avoid tableting failures
por: Osamura, Takashi, et al.
Publicado: (2018)

Yishen Xiezhuo formula ameliorates the development of cisplatin-induced acute kidney injury by attenuating renal tubular epithelial cell senescence
por: Zhang, Qiaoying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_96p8l99fo565gch3ra5firhv1a